Novo Nordisk, the creator of Wegovy, collaborates with OpenAI to accelerate medication development.
Danish pharmaceutical company Novo Nordisk, currently trailing Eli Lilly in the highly lucrative weight-loss drug segment, announced on…
Novo Nordisk Reduces Wegovy Prices by Up to 30% in Subscription Strategy to Compete with Eli Lilly
Novo Nordisk is set to introduce a discounted subscription plan for U.S. Wegovy patients who are self-paying for the medication, offering…
US FDA Grants Approval to Novo Nordisk’s Wegovy Tablet for Weight Management
On Monday (December 22), US regulators approved an oral version of Wegovy, a leading weight-loss drug, marking the first daily pill for…